36.45
price up icon1.45%   0.52
after-market Dopo l'orario di chiusura: 36.45
loading

Gsk Plc Adr Borsa (GSK) Ultime notizie

pulisher
Apr 21, 2025

Meningococcal Vaccines Market Size to Surpass $9.05 Billion, Globally, by 2032 at 10.4% CAGR: Coherent Market Insights - GlobeNewswire Inc.

Apr 21, 2025
pulisher
Apr 17, 2025

GSK's Pentavalent Meningococcal Jab Recommended for Use by ACIP - TradingView

Apr 17, 2025
pulisher
Apr 09, 2025

Best International Companies to Own: 2025 Edition - Morningstar

Apr 09, 2025
pulisher
Apr 03, 2025

Deadline Alert: GSK plc. (GSK) Investors Who Lost Money - GlobeNewswire

Apr 03, 2025
pulisher
Apr 03, 2025

Deadline Alert: GSK plc. (GSK) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - TradingView

Apr 03, 2025
pulisher
Mar 30, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming DeadlinesGSK - TradingView

Mar 30, 2025
pulisher
Mar 28, 2025

Is GSK plc (GSK) the Best ADR Stock to Buy According to Hedge Funds? - Insider Monkey

Mar 28, 2025
pulisher
Mar 27, 2025

GSK's Vaccine and HIV Portfolios Support Ongoing Innovation in Oncology and Immunology - Morningstar

Mar 27, 2025
pulisher
Mar 26, 2025

GSK Secures FDA Nod for Oral Antibiotic to Treat Urinary Tract Infection - Yahoo Finance

Mar 26, 2025
pulisher
Mar 23, 2025

GSK Investors Have Opportunity to Lead GSK plc Securities Fraud Lawsuit - PR Newswire

Mar 23, 2025
pulisher
Mar 20, 2025

Best international companies to own: 2023 Edition - Morningstar

Mar 20, 2025
pulisher
Mar 19, 2025

How Do Things Look For GSK Plc ADR (NYSE: GSK) In The Short-Term? - Stocks Register

Mar 19, 2025
pulisher
Mar 18, 2025

GSK Lead Plaintiff Deadline Approaching – Contact Robbins - GlobeNewswire

Mar 18, 2025
pulisher
Mar 18, 2025

GSK Lead Plaintiff Deadline Approaching – Contact Robbins LLP for Information About How to Lead the GSK PLC Class Action - TradingView

Mar 18, 2025
pulisher
Mar 14, 2025

Why GSK (GSK) is a Top Momentum Stock for the Long-Term - Yahoo Finance

Mar 14, 2025
pulisher
Mar 13, 2025

Bioengineered Protein Drugs Market Size to Cross USD 672.7 Billion by 2034, Growing at a CAGR of 6.2% - GlobeNewswire Inc.

Mar 13, 2025
pulisher
Mar 13, 2025

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick - Yahoo Finance

Mar 13, 2025
pulisher
Mar 12, 2025

GILD Data on Once-Yearly Lenacapavir for HIV Prevention Positive - Zacks Investment Research

Mar 12, 2025
pulisher
Mar 11, 2025

IONS/AZN Get FDA Nod for Amyloidosis Drug, Wainzua in Europe - Zacks Investment Research

Mar 11, 2025
pulisher
Mar 10, 2025

The Best Defensive Stocks to Buy Now - Morningstar

Mar 10, 2025
pulisher
Mar 06, 2025

Biotech Stocks Roundup: CMRX Up on JAZZ Bid, MRNA Up on Updates & More - Yahoo Finance

Mar 06, 2025
pulisher
Mar 06, 2025

The Best Women-Led Companies to Own: 2025 Edition - Morningstar

Mar 06, 2025
pulisher
Mar 04, 2025

GSK’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle

Mar 04, 2025
pulisher
Mar 03, 2025

Why weight-loss drugs are the top target of Medicare price negotiations - Equities News

Mar 03, 2025
pulisher
Feb 25, 2025

GSK Securities Class Action: GSK PLC Investors Should Contact Robbins LLP for Information About the Lead Plaintiff Deadline in the GSK Class Action Lawsuit - The Malaysian Reserve

Feb 25, 2025
pulisher
Feb 25, 2025

5 Undervalued Stocks That Crushed Q4 Earnings - Morningstar

Feb 25, 2025
pulisher
Feb 14, 2025

Shareholder Rights Law Firm Robbins LLP Reminds GSK Investors with Large Losses to Seek Advice on Leading the GSK PLC Class Action - PR Newswire

Feb 14, 2025
drug_manufacturers_general PFE
$22.04
price down icon 0.45%
drug_manufacturers_general SNY
$50.93
price up icon 0.06%
$104.33
price down icon 0.20%
$273.68
price down icon 1.30%
drug_manufacturers_general MRK
$77.85
price down icon 0.19%
drug_manufacturers_general NVS
$110.54
price down icon 0.29%
Capitalizzazione:     |  Volume (24 ore):